The role of dopamine in the pathophysiology of depression.
By B. Dunlop, C. Nemeroff. Archives of General Psychiatry, 2007
1,247 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/478b8c8b058e4456417dee568e767aa43f0efcad
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
- Michael T. Treadway
- David H. Zald
- A. Feder
- Elizabeth S. Paul
- Joshua W. Buckholtz
- M. Mendl
- Diego A. Pizzagalli
- Warren E. Lambert
In Psychiatry and Mental health
Citations in the corpus
- Understanding resilience (2013, background): “Some studies have found decreased levels of circulating dopamine in depression and elevated urinary and plasma dopamine concentrations in PTSD (Charney, 2004; Dunlop and Nemeroff, 2007).”
- Depression, Stress, and Anhedonia: Toward a Synthesis and Integrated Model (2014, background): “Owing to these findings, interest in the role of DA in the pathophysiology of depression has resurfaced (e.g., Dunlop & Nemeroff 2007).”
- Worth the ‘EEfRT’? The Effort Expenditure for Rewards Task as an Objective Measure of Motivation and Anhedonia (2009, background): “Not surprisingly, several theorists have proposed that the symptoms of anhedonia in humans, specifically symptoms of reduced motivation or wanting, are related to a deficiency of DA signaling in the ventral striatum [33,34].”
- Effects of Early Life Stress on Cognitive and Affective Function: An Integrated Review of Human Literature (2010, background): “Blunted mesolimbic DA transmission has been postulated in depression, particularly in the presence of anhedonia, low energy, loss of libido, and apathy (Dunlop and Nemeroff 2007; Hasler et al. 2008; Pizzagalli et al. 2009a, b).”
- Reconsidering Anhedonia in Depression: Lessons from Translational Neuroscience (2010, background): “…described below), subsequent research using neuroimaging, pharmacological and genetic methods in both humans and animals has provided some support for the claim that DA function is impaired in at least a sub-population of individuals with MDD (Dunlop and Nemeroff, 2007; Yadid and Friedman, 2008).”
- Cognitive bias as an indicator of animal emotion and welfare: Emerging evidence and underlying mechanisms (2009, background): “How might these reward-evaluation systems be influenced by affective state and hence alter the relative valuation of positive or negative outcomes in a judgement bias task? Activity of the DA system appears to be sensitive to environmental stressors and to be associatedwithmood disorders such as dep”
- Inflammatory Cytokines in Depression: Neurobiological Mechanisms and Therapeutic Implications (2013, background): “…2007, Furman et al., 2011, Capuron et al., 2012), and changes in DA synthesis, release and/or receptor signaling have been proposed as potential mechanisms that may contribute to anhedonic and psychomotor symptoms (Willner, 1983, Dunlop and Nemeroff, 2007, Stein, 2008, Felger and Miller, 2012).”
- The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain (2017, background): “The fact that dopaminergic drugs, such as pramipexole, are effective drugs for depression inhibition suggests that enhancing DA function may form at least a partial basis for treatment response of MDD [111].”